✦ LIBER ✦

Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: A metaanalysis from clinical studies

✍ Scribed by Bogazzi, F.; Manetti, L.; Raffaelli, V.; Lombardi, M.; Rossi, G.; Martino, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with low doses of cabergoline

✍ F. Bogazzi; S. Buralli; L. Manetti; V. Raffaelli; T. Cigni; M. Lombardi; F. Bore 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

RISK FACTORS FOR RESPONSE TO CARDIAC RES

✍ Alon Barsheshet; Ilan Goldenberg; Arthur J. Moss; Michael Eldar; David T. Huang; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Impact of High-Dose Atorvastatin Therapy

✍ Arsenault, Benoit J.; Boekholdt, S. Matthijs; Mora, Samia; DeMicco, David A.; Ba 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Risk factor profiles of patients with su

✍ David R. Holmes; Kathryn Davis; Bernard J. Gersh; Michael B. Mock; Mary B. Petti 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 816 KB

A Randomized Comparison of Antiarrhythmi

✍ Riccardo Cappato; Karl-Heinz Kuck; Jürgen Siebels; Rudolf Rüppel 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 104 KB

The mode of death in implantable cardiov

✍ Thijssen, Joep; van Rees, Johannes B.; Venlet, Jeroen; Borleffs, C. Jan Willem; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 1001 KB